
    
      This trial will compare the dose dense, G-CSF supported sequential administration of 4 cycles
      of 5-Fluoruracil (F) plus Epirubicin (E 75mg/m2) plus Cyclofosfamide (C) followed by 4 cycles
      of docetaxel versus 4 cycles of paclitaxel as adjuvant chemotherapy in women with axillary
      lymph node positive breast cancer
    
  